Patients with metastatic colorectal cancer may find hope with new FDA-approved treatment
This month brought some hopeful news to those battling metastatic colorectal cancer. The U.S. Food and Drug Administration (FDA) on November 8 approved a new oral drug called Fluzacra (fruquintinib) for the treatment of previously treated patients. metastatic colorectal cancer. Until now, patients with this disease have had limited treatment options, including surgery, chemotherapy, radiation […]